Crewella
Olympian
- Joined
- Aug 4, 2015
- Messages
- 37,892
https://www.gov.uk/government/news/...ve-against-hospitalisation-from-delta-variant
https://www.reuters.com/business/he...india-variant-english-health-body-2021-05-22/
https://www.healthline.com/health-n...-the-delta-variant#Vaccines-vs.-delta-variant
The analysis suggests:
- the Pfizer-BioNTech vaccine is 96% effective against hospitalisation after 2 doses
- the Oxford-AstraZeneca vaccine is 92% effective against hospitalisation after 2 doses
https://www.reuters.com/business/he...india-variant-english-health-body-2021-05-22/
A study by Public Health England found the Pfizer-BioNTech vaccine was 88% effective against symptomatic disease from the B.1.617.2 variant two weeks after the second dose.
That compared with 93% effectiveness against the B.1.1.7 "Kent" strain which is Britain's dominant COVID variant.
Two doses of the AstraZeneca vaccine were 60% effective against symptomatic disease from the Indian variant compared with 66% effectiveness against the Kent variant, PHE said.
That compared with 93% effectiveness against the B.1.1.7 "Kent" strain which is Britain's dominant COVID variant.
Two doses of the AstraZeneca vaccine were 60% effective against symptomatic disease from the Indian variant compared with 66% effectiveness against the Kent variant, PHE said.
https://www.healthline.com/health-n...-the-delta-variant#Vaccines-vs.-delta-variant
According to an analysis carried out by Public Health England, two doses of the Pfizer-BioNTech vaccine appeared to be about 88 percent effective against symptomatic disease and 96 percent effective against hospitalization with the delta variant.
The same study suggested that the vaccine was approximately 80 percent effective against preventing infection from the delta variant. Scientists came to this conclusion after analyzing 14,019 people with an infection, 166 of whom were hospitalized, in England.
Vaccines had a protective effect against infections with delta and hospital cases were milder, the study found.
The same study suggested that the vaccine was approximately 80 percent effective against preventing infection from the delta variant. Scientists came to this conclusion after analyzing 14,019 people with an infection, 166 of whom were hospitalized, in England.
Vaccines had a protective effect against infections with delta and hospital cases were milder, the study found.